CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 205 enrolled
Drug / intervention
reteplase 10+10 U +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00806403
NCT00806403Phase 4Completed
CompareCT.gov

Very Early Initiation of Treatment With Thrombolysis and Low Molecular Weight Heparin, Versus Abciximab and Low Molecular Weight Heparin Followed by Percutaneous Coronary Intervention, for Acute ST-Elevation Myocardial Infarction

Sahlgrenska University Hospital·interventional·Posted Dec 10, 2008·Updated Dec 10, 2008

In Brief

A Phase 4 clinical trial evaluating reteplase 10+10 U and primary PCI for Acute Myocardial Infarction. Completed, enrolled 205 participants across 5 sites.

Detailed Summary

The main objective is to compare a fibrinolytic strategy with an interventional strategy initiated as early as possible, preferably in the pre-hospital phase, with respect to resolution of ST-segment elevation at 120 minutes after inclusion and Thrombolysis In Myocardial Infarction (TIMI) flow grade evaluated at a mandated coronary angiography 5 to 7 days after inclusion.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Myocardial Infarction
CountriesSweden
CollaboratorsStockholm South General Hospital, Region Örebro County, Norra Alvsborgs Lans Hospital, Trollhattan, Varberg Hospital, Sweden

Timeline

Phase 4CompletedFinished
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 10, 2008
Enrollment StartNov 1, 2001
Primary CompletionJun 1, 2003
Study CompletionJun 1, 2004
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 17.6 years ago

Interventions

reteplase 10+10 Udrug

comparison to primary PCI

primary PCIprocedure

comparison to thrombolysis